Elissa Schwartz Net Worth & Insider Trades

Elissa Schwartz Galectin Therapeutics Inc

As of January 30, 2023

What is Elissa Schwartz's Net Worth?

The current estimated net worth of Galectin Therapeutics Inc's Elissa Schwartz is estimated to be about $1.44K . Elissa Schwartz owns about 1,000 units of Galectin Therapeutics Inc common stock. In the last 2 years at Galectin Therapeutics Inc, Elissa Schwartz has sold an estimated value of $0 worth.

What is Elissa Schwartz's Past Insider Trading?

Elissa Schwartz's largest purchase order was 1,000 units , worth over $2K on January 24, 2022. In total, Elissa Schwartz has made about 4 transactions over 2 years of their time at Galectin Therapeutics Inc. Elissa Schwartz usually trades in January, with the busiest year in 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Elissa Schwartz

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Elissa Schwartz's' Mailing Address?

  • Mailing address is 235 SW Church St. Pullman WA 99163 WA

What are Galectin Therapeutics Inc's Past Insider Trades?

Galectin Therapeutics Inc's most recent insider trade came on July 20, 2023 by Kary Eldred who bought 1,598 units worth $2.85K . In the last 12 years, insiders at Galectin Therapeutics Inc have sold an estimated value of $28.69M and bought an estimated value of $68.61M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Joel Lewis, President and CEO,  James Czirr,  and X Capital Management Llc .

GALECTIN THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...